Multidrug-Resistant Reference Materials

Multidrug-resistance (MDR) among infectious microorganisms is a serious health concern that has contributed to increases in morbidity, mortality, and expense in healthcare settings. ATCC offers a complete set of solutions for MDR research, including microbial strains exhibiting resistance to numerous antimicrobial agents and primary cells for drug toxicity studies.

In the last two decades, multidrug-resistant (MDR) microbial strains have been attributed to numerous infections worldwide. Regrettably, current treatment for these infections is severely limited, thus necessitating the development of novel prevention methods and therapeutics.

ATCC understands the danger and growing concern behind the spread of MDR strains. To aid in the prevention and treatment of MDR-associated infections, ATCC offers a complete set of solutions to advance your research:

  • Drug-resistant microbial reference strains from various clinical and environmental sources
  • Primary cells for drug toxicity screening studies
  • Media and reagents to support cellular growth

All ATCC reference materials are produced under ISO 9001:2008 certified and ISO/IEC 17025:2005 accredited processes, ensuring reliability and reproducibility of research data. These strains are ideal for the development, verification, and evaluation of rapid detection methods, innovative therapeutic techniques, novel antibiotics, and updated sterility protocols.

Check out the resources below to find products relevant to your research and applications. 

Drug-Resistant Microbial Strains

ATCC offers a wide array of clinically relevant MDR strains isolated from a variety of hospital- and community-acquired sources. These cultures are useful for studying the genetic variations between strain types, the in vitro evaluation of disinfectants and novel antimicrobials, and establishing the performance characteristics of molecular-based assays. Search for strains by category:




ATCC®Microbial Panels

ATCC Microbial Panels enable faster, more intelligent choices when selecting cultures for microbial research. Our collection of MDR panels comprise ATCC Genuine Cultures® grouped together based on genetic markers conferring drug resistance, including vancomycin-resistant enterococci (VRE), methicillin-resistant Staphylococcus aureus (MRSA), carbapenem-resistant Enterobacteriaceae, and drug-resistant Candida albicans.

Browse our microbial panels

ATCC® Primary Cells

During the development of novel antimicrobial drugs, it is imperative to ensure product quality, safety, and efficacy. In vitro testing using primary cells derived from various organ systems and donors can provide a quick mechanism for screening therapeutics for any potential toxic effects. To aid in your toxicity studies, ATCC offers a variety of primary cells procured from diverse tissue sources combined with matched and optimized reagents. 

Search our collection of primary cells